QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

CLDX

QT49Celldex Therapeutics, Inc.
NASDAQ·Healthcare·Biotechnology·USA
Latest market price
32.43
-0.50-1.52%
OverviewShort InterestFilings
CLDXQT49Celldex Therapeutics, Inc.·NASDAQ
OverviewShort InterestFilings
32.43-1.52%

Latest SEC Filings

Form category
Filing Date ▾Report DateFormDescriptionFilingDocument
May 15, 2026May 15, 2026SC 13G/ASC 13G/A
May 15, 2026May 15, 2026SC 13G/ASC 13G/A
May 12, 2026May 12, 2026SC 13GBeneficial ownership statement (passive)
May 07, 2026May 07, 20268-KCurrent report
May 07, 2026May 07, 202610-QQuarterly report
May 06, 2026May 06, 2026SC 13G/ASC 13G/A
Apr 29, 2026Apr 29, 2026SC 13GBeneficial ownership statement (passive)
Apr 29, 2026Apr 29, 2026ARSARS
Apr 29, 2026Apr 29, 2026DEF 14ADefinitive proxy statement
Apr 02, 2026Apr 02, 20268-KCurrent report
Apr 02, 2026Apr 02, 2026424B5424B5
Apr 01, 2026Apr 01, 2026424B5424B5
Mar 26, 2026Mar 26, 2026SC 13G/ASC 13G/A
Mar 10, 2026Mar 10, 2026SC 13G/ASC 13G/A
Feb 25, 2026Feb 25, 20268-KCurrent report
Feb 25, 2026Feb 25, 202610-KAnnual report
Feb 10, 2026Feb 10, 2026SC 13G/ASC 13G/A
Feb 09, 2026Feb 09, 2026SC 13GBeneficial ownership statement (passive)
Jan 06, 2026Jan 06, 20264Statement of changes in beneficial ownership
Dec 17, 2025Dec 17, 20254Statement of changes in beneficial ownership
Dec 08, 2025Dec 08, 20254Statement of changes in beneficial ownership
Nov 17, 2025Nov 17, 20254Statement of changes in beneficial ownership
Nov 14, 2025Nov 14, 2025SC 13G/ASC 13G/A
Nov 14, 2025Nov 14, 2025SC 13G/ASC 13G/A
Nov 14, 2025Nov 14, 2025SC 13GBeneficial ownership statement (passive)
#1 / 25 of 270
Page
▼
/ 11